For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Documents
N-Nitroso Furosemide analysis using a SCIEX 5500+ system
Furosemide is used to treat fluid retention caused by heart failure, liver scarring or kidney disease. It is also used in the treatment of high blood pressure. Furosemide works by reducing the amount of sodium reabsorption in the kidneys and can also result in the lowering of other plasma electrolytes such as potassium. As with any routinely prescribed medication, it is important to ensure purity of the active pharmaceutical ingredient together with any formulated product. As Furosemide is a secondary amine, there is the potential that an NDSRI (nitrosamine drug substance related impurity) can be formed. Such NDSRIs have the potential to be carcinogenic and therefore the presence of NDSRIs must be monitored. This technical note describes the separation and detection of Furosemide and it’s associated NDSRI.

N-Nitroso Furosemide analysis using a SCIEX 5500+ system

Furosemide is used to treat fluid retention caused by heart failure, liver scarring or kidney disease. It is also used in the treatment of high blood pressure. Furosemide works by reducing the amount of sodium reabsorption in the kidneys and can also result in the lowering of other plasma electrolytes such as potassium. As with any routinely prescribed medication, it is important to ensure purity of the active pharmaceutical ingredient together with any formulated product. As Furosemide is a secondary amine, there is the potential that an NDSRI (nitrosamine drug substance related impurity) can be formed. Such NDSRIs have the potential to be carcinogenic and therefore the presence of NDSRIs must be monitored. This technical note describes the separation and detection of Furosemide and it’s associated NDSRI.
save_alt DOWNLOAD

Can't view? Disable your browser's pop-up blocker.

Document Type:
Technical Notes
Brands:
Separation Modes:
Reversed Phase

N-Nitroso Furosemide analysis using a SCIEX 5500+ system

Furosemide is used to treat fluid retention caused by heart failure, liver scarring or kidney disease. It is also used in the treatment of high blood pressure. Furosemide works by reducing the amount of sodium reabsorption in the kidneys and can also result in the lowering of other plasma electrolytes such as potassium. As with any routinely prescribed medication, it is important to ensure purity of the active pharmaceutical ingredient together with any formulated product. As Furosemide is a secondary amine, there is the potential that an NDSRI (nitrosamine drug substance related impurity) can be formed. Such NDSRIs have the potential to be carcinogenic and therefore the presence of NDSRIs must be monitored. This technical note describes the separation and detection of Furosemide and it’s associated NDSRI.

Can't view? Disable your browser's pop-up blocker.